Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-26

Clinical Trial Update: Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating metformin hydrochloride vs placebo for cancer chemoprevention in oral potentially malignant lesions (oral cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Ain Shams University | Conditions: Oral Cancer | Phase 4 | Status: UNKNOWN